Alphatec Holdings Inc (ATEC)vsNovartis AG ADR (NVS)
ATEC
Alphatec Holdings Inc
$9.66
+0.10%
HEALTHCARE · Cap: $1.28B
NVS
Novartis AG ADR
$158.83
-0.25%
HEALTHCARE · Cap: $290.96B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 7103% more annual revenue ($56.69B vs $787.08M). NVS leads profitability with a 22.5% profit margin vs -15.9%. ATEC appears more attractively valued with a PEG of 0.48. NVS earns a higher WallStSmart Score of 51/100 (C-).
ATEC
Hold42
out of 100
Grade: D
NVS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.4%
Fair Value
$20.23
Current Price
$9.66
$10.57 discount
Margin of Safety
-70.9%
Fair Value
$92.73
Current Price
$158.83
$66.10 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 31.8%
Keeps 23 of every $100 in revenue as profit
Generating 5.6B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -686.7% — below average capital efficiency
Negative free cash flow — burning cash
0.8% revenue growth
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : ATEC
The strongest argument for ATEC centers on PEG Ratio. Revenue growth of 13.6% demonstrates continued momentum. PEG of 0.48 suggests the stock is reasonably priced for its growth.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 22.5% and operating margin at 31.8%.
Bear Case : ATEC
The primary concerns for ATEC are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 33.03 is elevated, increasing financial risk.
Bear Case : NVS
The primary concerns for NVS are Revenue Growth, Altman Z-Score, Debt/Equity.
Key Dynamics to Monitor
ATEC profiles as a turnaround stock while NVS is a value play — different risk/reward profiles.
ATEC carries more volatility with a beta of 0.85 — expect wider price swings.
ATEC is growing revenue faster at 13.6% — sustainability is the question.
NVS generates stronger free cash flow (5.6B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (51/100 vs 42/100), backed by strong 22.5% margins. ATEC offers better value entry with a 33.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alphatec Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?